Cytokinetics, Incorporated CYTK has entered a pivotal phase following the FDA approval of its first commercial product, ...

In this week’s View, Dr. Eagle looks at the differential effect of bisoprolol versus verapamil in nonobstructive hypertrophic cardiomyopathy (HCM) treatment. He then explores lower heart failure (HF) ...

Feeling constantly tired might have less to do with your schedule and more to do with what’s sitting in your medicine cabinet ...

Jane Manecke, a middle blocker from the state of Illinois, has committed to the Wisconsin Badgers. Manecke is the sixth high school recruit to join the Badgers' 2026 class. Her commitment brings the ...

Wisconsin volleyball has some more talent coming in at middle blocker. Class of 2026 recruit Jane Manecke announced her commitment to the Badgers on March 10 via social media. Manecke, a prospect from ...

Bisoprolol but not verapamil reduced peak oxygen consumption (pVO 2) in patients with nonobstructive hypertrophic cardiomyopathy (HCM), according to research published March 3 in JACC. In this ...

CalciMedica’s stock nosedived after the biotech abandoned a phase 2 study of its calcium release-activated calcium (CRAC) channel inhibitor in patients with acute kidney injury (AKI) over a “safety ...

The FDA had previously turned back the heart rhythm nasal spray twice, once in late 2023 with a refusal to file letter and again in March this year, when it flagged manufacturing issues. More than two ...

If you have an abnormal heart rhythm or another heart condition like high blood pressure, a beta-blocker may be a key part of your treatment plan. Beta-blockers, such as atenolol, metoprolol, and ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first polypill designed for initial treatment of hypertension. Approval was based on the ...